Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference49 articles.
1. Treatment of erythropoietin deficiency in mice with systemically administered siRNA;Querbes;Blood,2012
2. Promise and challenge of RNA interference-based therapy for cancer;Petrocca;J Clin Oncol,2011
3. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs;Soutschek;Nature,2004
4. A nanoformulation of siRNA and its role in cancer therapy: in vitro and in vivo evaluation;Jagani;Cell Mol Biol Lett,2013
5. Interfering with disease: a progress report on siRNA-based therapeutics;de Fougerolles;Nat Rev Drug Discov,2007
Cited by 116 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. VDAC1-Based Peptides as Potential Modulators of VDAC1 Interactions with Its Partners and as a Therapeutic for Cancer, NASH, and Diabetes;Biomolecules;2024-09-09
2. Mitochondrial VDAC1 Silencing in Urethane-Induced Lung Cancer Inhibits Tumor Growth and Alters Cancer Oncogenic Properties;Cancers;2024-08-26
3. Gene signatures of endoplasmic reticulum stress and mitophagy for prognostic risk prediction in lung adenocarcinoma;IET Systems Biology;2024-05-30
4. Urease and human glioblastoma (U87) cells growth inhibitory iridoid glycoside acetates from Nyctanthes arbor-tristis Linn.;Natural Product Research;2024-04-22
5. LncRNA H19 inhibition impairs endoplasmic reticulum-mitochondria contact in hepatic cells and augments gluconeogenesis by increasing VDAC1 levels;Redox Biology;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3